Treatment
Drug clinical trials
We’re tracking 1,253 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT04393389Recruiting
Follow-up study for a drug-coated balloon in leg arteries
This is a post-market follow-up study of a drug-coated balloon used to open blocked leg arteries. It checks how safe the device is and how well it works over time after your procedure.
Halle, Saxony-AnhaltAges 18 years+ - NCT06156683Recruiting
Kesimpta pregnancy safety study using real-world data
This study looks at the safety of Kesimpta (a multiple sclerosis medication) during pregnancy. It compares outcomes for women who took Kesimpta or other MS drugs while pregnant to those who did not.
BaselAges 18 years+ - NCT07788456RecruitingPhase 4
Sequential combination therapy for newly diagnosed ITP in adults
This study tests a combination of multiple drugs given in sequence to adults with newly diagnosed immune thrombocytopenia (ITP), a condition of low platelets. The goal is to see if this approach improves platelet counts and is safe.
TianjinAges 18–75 - NCT07789639RecruitingPhase 4
Sunscreen effectiveness study on back skin
This study tests two sunscreen products to see how well they protect the skin from sun damage. Participants will have a small area on their back treated and then exposed to a controlled amount of UV light to measure the products' effectiveness.
Winston-Salem, North CarolinaAges 18–75 - NCT06550167Recruiting
Nano PSO for brain protection in substance users
This trial tests whether a supplement called Nano PSO can help protect the brain in people who have used methamphetamines, cocaine, and cannabis for at least three years. It looks at effects during the withdrawal period for men currently in residential treatment.
Guadalajara, JaliscoAges 18–50 - NCT07780383RecruitingPhase 1
Single-dose study for healthy adults and early Alzheimer's participants
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
Anaheim, CaliforniaAges 18–80 - NCT06553443RecruitingPhase 3
Comparing coated and plain balloons for dialysis access narrowing
This trial tests whether a drug-coated balloon works better than a plain balloon to open up narrowed spots in your dialysis access. If you have a failing AVF with a narrowing that can be treated, this study may help improve your dialysis.
SingaporeAges 21 years+ - NCT07777887Recruiting
Finding lymph nodes during testicular cancer surgery
This trial tests a way for surgeons to find the first lymph nodes that testicular cancer might spread to, using a special camera and a dye. It could help doctors decide if you need extra treatment after surgery to remove the testicle.
Saint Petersburg, Sankt-PeterburgAges 18–60 - NCT07779551Enrolling by invitation
Pain relief after thyroid surgery: comparing two numbing drugs
This study compares two medications, bupivacaine and ropivacaine, given as a neck block before thyroid surgery to see which provides better pain relief after the operation. It may help reduce post-surgery discomfort.
Sargodha, Punjab ProvinceAges 20–40 - NCT06550102Recruiting
Drug response profiling for blood cancers
This study collects tumor samples from children and young adults with blood cancers to test how their cancer responds to different drugs. The goal is to find more effective treatments for each person.
Zurich, Canton of ZurichAges Up to 40 years - NCT06443151Recruiting
Blood Vessel Health After Spinal Cord Injury
This study looks at how blood vessel health is affected in people with long-term spinal cord injury (over 1 year). It tests whether blood vessel function plays a role in heart and circulatory risk.
Englewood, ColoradoAges 18–89 - NCT07771283Enrolling by invitation
Comparing ovarian stimulation methods for IVF
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
KampalaAges 18–40 - NCT05420935Recruiting
Study of antibodies after operating-room allergic reactions
This study looks at different kinds of allergy-related antibodies in people who had an allergic reaction during surgery. The goal is to better understand what immune signals are involved so future allergy prevention and care can improve.
Paris, ParisAges 18–70 - NCT07751978Recruiting
HIV care support for women who inject drugs
This study tests a program to help women living with HIV who also inject drugs stay engaged in their HIV care. It aims to reduce stigma and improve health outcomes.
Kyiv, Kyiv OblastAges 18 years+ - NCT07749716RecruitingPhase 2
Oral tablet for severe hair loss
This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.
Beijing, Beijing MunicipalityAges 18–65 - NCT07741825Recruiting
Mindfulness training to prevent relapse for peer support workers
This study tests a mindfulness-based program to help people who work as peer support specialists in substance use recovery reduce their risk of relapse. It may help you manage cravings and stay healthy in your role.
Austin, TexasAges 18–100 - NCT07743606Enrolling by invitationPhase 3
Pain medicine after lower back fusion surgery
This study tests whether taking a nonsteroidal anti-inflammatory drug (NSAID) like ibuprofen after lumbar spine fusion surgery is safe and helps with pain without affecting bone healing. It may offer an alternative to stronger pain medicines.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06612632RecruitingPhase 1/Phase 2
Retrying Immunotherapy for Solid Tumors After First Trial
This trial tests whether giving immunotherapy again can help people with solid tumors who have already tried an experimental treatment in a clinical trial and it stopped working. It looks for patients whose cancer has returned or spread and who can start the new treatment within 12 weeks of their last therapy.
BeijingAges 18 years+ - NCT06317714Recruiting
Long-term follow-up and quality of life after cancer treatment
This study follows patients over time to see how anticancer treatments affect their quality of life. It's for adults who receive special cancer drugs and also get other support at the Rafael Institute.
Levallois-Perret, Institut RafaelAges 18 years+ - NCT07737054RecruitingEarly Phase 1
Psilocybin therapy for PTSD
This trial tests a type of therapy that uses psilocybin (a safe, natural substance found in certain mushrooms) to help people with PTSD. It combines talk therapy with the medicine to see if it can reduce trauma symptoms.
Tel AvivAges 21–65 - NCT07736937RecruitingPhase 1/Phase 2
Study of TUB-040 with Standard Drugs for Ovarian Cancer
This study tests a new medicine called TUB-040, given together with standard ovarian cancer drugs like carboplatin and bevacizumab. It is for women with ovarian cancer that has returned after responding to platinum-based chemotherapy and is growing again. The goal is to see if this combination can help control the cancer.
Los Angeles, CaliforniaAges 18 years+ - NCT07729579RecruitingPhase 1
Study of a drug for actinic keratosis on arms or face
This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.
College Station, TexasAges 18–85 - NCT07730723RecruitingPhase 2/Phase 3
Nicorandil for moderate to severe rheumatoid arthritis
This study tests whether a heart medication called nicorandil can help reduce arthritis symptoms when added to your current treatment. It is for people with moderate to severe rheumatoid arthritis who have been stable on their current treatments.
Cairo, AbbasiaAges 18 years+ - NCT06630923RecruitingPhase 3
Preventing kidney worsening with IV albumin in heart failure
This trial tests if giving a medicine called albumin through a vein can help prevent kidney function from getting worse in people hospitalized with worsening heart failure and liver problems. It may be an option if other treatments haven't worked.
Alexandroupoli, EvrosAges 18–95
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,253 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.